Heart Failure is a consequence of Heart Attack

Have you recently suffered from a Heart Attack?

A Clinical Research Study Could Provide Options to Millions.

Heart attacks (or acute myocardial infarction) affect approximately 7 million individuals every year. Despite advancements in its treatment, a significant unmet need persists. More than one-third of all MI patients consequently have developed heart failure or heart-related conditions after 5 years.

We’re conducting a clinical research trial on an experimental medication, which, in addition to normal care, may reduce the risk of heart failure and death.

You may be eligible to participate in the MI Study if you:

  • Are 18 years old and above
  • Have recently suffered from a heart attack in the past 2 weeks
  • Diagnosed with myocardial infarction or at a high risk of heart failure

The MI Clinical Trials are being conducted to help doctors and researchers learn more about the study drug that may aid people who have been hospitalized due to heart attacks. People with heart attacks are more likely to develop heart failure. We are investigating whether the study drug along with regular health care may be able to lower the risk of heart failure.

*The Acute Myocardial Infarction Clinical Trial is free of cost to both you and your insurance provider. You will receive a stipend for every visit to the site you complete if you qualify and decide to participate in the research study. And all participants receive study-related care from doctors & health care professionals, free of cost.

**If you decide to be a part of the research study or would like more information, please fill the form so that we can see if you may qualify. Someone from the research staff will give you a call to confirm eligibility. Keep in mind that your participation is entirely voluntary. If you do decide to take part in the study, you have the right to withdraw consent at any time.

Please provide YOUR contact information only.
Acute Myocardial Infarction study

About the MI Study

Revival Research Institute is conducting a phase 3 clinical study on an oral medication that may be able to help people who have recently suffered through a heart attack. The MI Study is a double-blind, placebo-controlled research study. This means that neither you nor your study doctor will know which medication you have received. You could either receive the study drug or the placebo (which is a pill but without the active ingredient).

If you have been diagnosed with acute myocardial infarction or have recently suffered from a heart attack, you may be eligible to participate in the research study. People who’ve suffered from heart attacks are at high risk for heart failure. The study will continue for 12 – 24 months with 2 visits at the clinic, 3-6 remote visits, and telephonic follow-ups.

*The study drug procedures are free of cost for all the participants. If you decide to participate in the study, you will receive study-related care from experienced healthcare staff including doctors, cardiologists, and nurses.

Get Started: What to Expect?

We are conducting a research study to observe whether the experimental drug along with the standard of care treatment may be able to help people who’ve suffered from recent heart attacks. The drug is not FDA approved which means it is not available in the market and cannot be used for any other purpose except for in this study. There is an equal opportunity for all participants to either receive the study drug or the placebo (pills without the active ingredient). You nor your study doctor will know which medication you’ve received. Not disclosing the treatment assignment allows researchers to tell without bias whether the study drug is safe and effective.

To complete the screening process and see if you are eligible to participate in the research study, you might be invited to the study clinic. The study doctor will go through all the details about the clinical research trials including the risks and benefits, what is expected of you, how long the study will be, and any other questions you have. This will be done in the Informed Consent Process. We encourage all participants to ask as many questions as they’d like before signing the consent form and deciding to participate in the clinical trial.

*Participation in the clinical research trial is free of cost to you and your health insurance. Patient health is the top priority in our clinical trial. If the participant suffers from any adverse event, the participant’s information along with the treatment will be disclosed to the study doctor to ensure the participant’s well-being.

Condition

Acute Myocardial Infarction (Heart Attack)

Length of Study Treatment

12 – 24 months

Number of Study Visits

1-2 visits onsite & 3-6 remote visits

About Acute Myocardial Infarction (Heart Attack)

acute myocardial infarction trials

Around 1.5 million Myocardial Infarction cases occur each year in the United States. It ranks in the most significant causes of death and poor health across the globe and results in over 1 million hospitalizations per year in the United State alone.

A myocardial infarction occurs when there is an insufficient supply of oxygen to the heart muscle, due to reduced blood flow for a prolonged period of time. This occurs due to a blockage, which is most often a build-up of fat and cholesterol accumulation, called plaque.

You don’t have to have heart failure to have a heart attack. Many people have undiagnosed heart failure and their first symptom is a heart attack.
Sudden cardiac arrest is the earliest symptom of heart disease in a considerable proportion of individuals.

What Puts You Most at Risk for an MI?

  • Hypertension 
  • High Cholesterol 
  • Diabetes 
  • Smoking 
  • Excessive alcohol consumption 
  • Sedentary Lifestyle
  • Undue mental stress  
  • Diet high in saturated fats 
  • Menopausal women

Heart Attack Warning Signs!

  • Pain in the upper body that spreads to the shoulders, neck, arms, or jaw
  • Sudden and severe breathing difficulty and  shortness of breath
  • Rapid or irregular pulse
  • Worsening chest pain 
  • Nausea, indigestion, heartburn or abdominal pain
  • Lightheadedness or sudden dizziness
  • Cold sweats

Quick medical attention can save lives. If you or someone you know has any of the above warning signs, act right away. Call 911, or your local emergency number as soon as possible.  

Frequently Asked Questions

What is Acute Myocardial Infarction?

Acute Myocardial Infarction is also known as a heart attack. This occurs when the blood supply to the heart is suddenly blocked due to a buildup of cholesterol or plaque. This could cause the heart muscle to die, either a few cells of the heart or an entire section.

When does an Acute Myocardial Infarction (AMI) or heart attack occur?

It occurs when one or more areas of the heart does not receive enough blood supply which cuts off the oxygen to that part of the heart. There is usually a blood clot that forms in the area where there is a buildup in the blood vessels. When the blood clot breaks off or ruptures, heart attacks or acute myocardial infarction occurs.

Are there any risks in participating in the MI Study?

Every clinical trial has its risks and benefits. If the medication is effective, it may reduce some of the symptoms of your condition. However, the medication might not improve your condition or it may remain the same for the duration of the clinical trial. All the risks and benefits of participating in the clinical trials will be explained to you during the informed consent process. Participants will be monitored for any risks or side effects during the course of the trial.

What is the location of the Myocardial Infarction Clinical Trial?

The study site will be located within a 50-mile radius of you. The location of the site of this study is in Sherman and McKinney, Texas

Will I need to pay to participate in the clinical trial?

Participation in the clinical trial is free of cost to both you and your health insurance. If you decide to participate and qualify for the research study, you might receive a stipend for every visit completed. The study doctor will discuss this with you during the Informed Consent Process.